Literature DB >> 31272347

Sugammadex for Reversal of Neuromuscular Blockade: Uses and Limitations.

Jesse Hawkins1, Sandeep Khanna1, Maged Argalious1.   

Abstract

Sugammadex is a reversal agent that was engineered to reverse the effects of aminosteroid muscle relaxants. It is a modified gamma-cyclodextrin, i.e. a large glucose molecule bound in a ring-like structure. Sugammadex, when injected intravenously, creates a concentration gradient favoring the movement of aminosteroid muscle relaxants from the neuromuscular junction back into the plasma, and then encapsulates the aminosteroid muscle relaxants within its inner structure by forming tight water-soluble complexes. The dissociation of the aminosteroidal muscle relaxant from the post-synaptic acetylcholine receptors is responsible for the termination of neuromuscular blockade. This review article presents the current indication, mechanism of action, limitations, side effects and contraindications of sugammadex. An overview of monitoring of the adequacy of reversal of aminosteroid muscle relaxants with sugammadex is presented. Moreover, the use of sugammadex in special situations, including "cannot intubate cannot oxygenate" scenarios is also described. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Sugammadex; aminosteroids; neuromuscular blocker; neuromuscular monitoring ; neuromuscular reversal; non-depolarizing muscle relaxants.

Year:  2019        PMID: 31272347     DOI: 10.2174/1381612825666190704101145

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  A Real-Time Artificial Intelligence-Assisted System to Predict Weaning from Ventilator Immediately after Lung Resection Surgery.

Authors:  Ying-Jen Chang; Kuo-Chuan Hung; Li-Kai Wang; Chia-Hung Yu; Chao-Kun Chen; Hung-Tze Tay; Jhi-Joung Wang; Chung-Feng Liu
Journal:  Int J Environ Res Public Health       Date:  2021-03-08       Impact factor: 3.390

2.  Diaphragm ultrasound to evaluate the antagonistic effect of sugammadex on rocuronium after liver surgery in patients with different liver Child-Pugh grades: study protocol for a prospective, double-blind, non-randomised controlled trial.

Authors:  Shujun Sun; Yan Sun; Rui Chen; Chunlin Yao; Haifa Xia; Xiangdong Chen; Yun Lin; Shanglong Yao
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692

3.  Recovery Profile of Sugammadex versus Neostigmine in Pediatric Patients Undergoing Cardiac Catheterization: A Randomized Double-Blind Study.

Authors:  Hosam I El Said Saber; Sherif A Mousa; Ahmed Refaat AbouRezk; A Zaglool
Journal:  Anesth Essays Res       Date:  2022-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.